Prospective study of endoscopic subcutaneous mastectomy versus open subcutaneous mastectomy with areola incision in the treatment of Gynaecomastia

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046415

Enrollment

Unknown

Registered

2021-05-15

Start date

2021-05-15

Completion date

Unknown

Last updated

2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynaecomastia

Interventions

endoscopic subcutaneous mastectomy versus open subcutaneous mastectomy with areola incision:none

Eligibility

Sex/Gender

Male

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years, especially young male patients; 2. The preoperative ultrasound examination showed obvious glandular components in the breast. 3. The maximum diameter of the breast is greater than 5 cm; the patient suffers from Simon (Simon) IIB grade or higher gynecomastia. 4. Surgery or injury will not cause large scars on the surface of the breast. 5. There is no serious arrhythmia or cardiac dysfunction. 6. No obvious bleeding tendency. 7. Able and willing to sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Male breast cancer patients; 2. Patients who use drugs, supplements or illegal drugs to cause transient gynecomastia; 3. Participate in other trials.

Design outcomes

Primary

Measure	Time frame
BODY-Q score-related scale;	—

Countries

China

Contacts

Public ContactDu Zhenggui

West China Hospital of Sichuan University

386844794@qq.com+86 18980605774,+86 13880768222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026